COVID-19

Vanderbilt University Medical Center is evaluating razuprotafib, a drug used to treat glaucoma, in a new randomized, investigational trial for the prevention and treatment of acute respiratory distress syndrome (ARDS) in adult patients with moderate to severe COVID-19. Read More

The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.  Read More

After evaluating the ability of more than 1,500 monoclonal antibodies to bind and neutralize the COVID-19 virus, SARS-CoV-2, in the laboratory, AstraZeneca signed an exclusive license to six candidate antibodies in Vanderbilt’s portfolio. Read More

The investigational antiviral drug remdesivir can shorten the time to recovery in adults hospitalized with COVID-19, according to preliminary results of a clinical trial published last month in The New England Journal of Medicine. Read More

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center. Read More

Researchers are using imaging and diagnostic pathology to examine postmortem hearts donated by victims of COVID-19 to gain a better understanding of how the coronavirus that causes COVID-19 affects the heart. Read More

As Nashville cautiously begins to emerge from its two-month-long COVID-19 Safer at Home response, so too are the labs and facilities at Vanderbilt University Medical Center. Read More

Mark Abkowitz, professor of civil and environmental engineering, discusses the challenges of managing a natural disaster during a pandemic. Read More

Psychological research demonstrates that noticing errors in what we read is often difficult, and that those errors can affect our later beliefs, even when we know they’re wrong. Read More

As the COVID-19 pandemic continues to upend lives in countless ways, members of the Vanderbilt community have shown remarkable resilience in the face of the crisis. Read More

Vanderbilt Magazine raises a glass of its own to the tenacious, accomplished and always adaptable Class of 2020. Cheers to you all. Read More

From the front lines of patient care to collaborating with scientists across the globe searching for treatments and vaccines, Vanderbilt University Medical Center and Vanderbilt University researchers have been working for months to combat the COVID-19 pandemic. Read More

At a time when we are physically separate, the connections embodied by our One Vanderbilt community have become even more vital. Read More

Vanderbilt Athletics lit up the video board at Hawkins Field on March 30 with a special tribute to all the health care workers at Vanderbilt University Medical Center and elsewhere who are on the front lines of the battle against COVID-19. Read More

The poem originally appeared in The New Yorker’s April 6, 2020, issue. Read More

To date, Vanderbilt University Medical Center experts have appeared in 28,984 media placements related to COVID-19 since Jan. 15, reaching a cumulative audience of nearly 77 billion. Read More

Monoclonal antibodies against Marburg virus — a more lethal cousin of the RNA virus that causes COVID-19 — may aid in the development of antibody "cocktails" to counter viral infection. Read More

Kathleen McKiernan, assistant professor of economics, discusses how the economy can restart after the devastating effects of the COVID-19 pandemic. Read More

Whether you’re taking a class, conducting a meeting or gathering with friends, just about everyone is jumping into virtual chats. Here are five easy tips to improve how your virtual chat looks and sounds. Read More